New York hospitals are facing potential staff shortages as they prepare to fire unvaccinated employees. Last month, the state’s health department mandated that all healthcare employees receive their first vaccine dose by September 27. (Reuters)

As schools attempt to avoid COVID-19 outbreaks, many have struggled to implement strong testing protocols. “While some of the logistics are getting easier, there’s a pretty fragmented approach from school district to school district as to whether and how testing is being used,” said pediatrician Dr. Laura Faherty. (The New York Times)

Biohaven’s neurological disorder drug, verdiperstat, failed to show efficacy in treating patients with multiple system atrophy (MSA). The drug did not reach its primary or secondary endpoints in a Phase III trial. (Endpoints News)

A former Theranos lab director testified Friday that he felt pressured to support tests in which he lacked confidence. He also said he believed the company “was more about PR and fundraising than patient care.” (CNBC Weekly)

Healthcare providers are working to define who should receive Biogen’s Alzheimer’s drug Aduhelm and what constitutes mild cognitive impairment. The Food and Drug Administration limited the drug to individuals with mild cognitive impairment or early-stage Alzheimer’s. (The Washington Post)